Endo Pharmaceutical’s stock suffers the biggest one-day plunge in 14 years on nearly eight times average volume, on th heels of the drugmaker’s disappointing outlook and an analyst downgrade.
read more
Endo Pharmaceutical’s stock suffers the biggest one-day plunge in 14 years on nearly eight times average volume, on th heels of the drugmaker’s disappointing outlook and an analyst downgrade.
read more